By Josh White
Date: Monday 02 Jun 2025
(Sharecast News) - Polarean Imaging announced on Monday that it has received approval from the US Food and Drug Administration to expand the use of its lung imaging agent Xenoview to include children aged six and older, opening access to an additional one million potential patients.
Capital Markets Day | 03-Jun-2025 | 07:00 | RNS |
Growing collaboration with NYKHM | 03-Jun-2025 | 07:00 | RNS |
Form 8.3 - Assura plc | 03-Jun-2025 | 07:00 | RNS |
Form 8.3 - Primary Health Properties plc | 03-Jun-2025 | 07:00 | RNS |
Director/PDMR Shareholding | 02-Jun-2025 | 15:45 | RNS |
Investment Column:Consort Medical | 02-Dec-2011 | The Independent |
Investment Column:Lidco | 27-Oct-2011 | The Independent |
FTSE live: London steady; Burberry down | 14-Mar-2011 | Daily Mail |
FTSE close: Tesco up; Mining shares surge | 08-Dec-2010 | Daily Mail |
Investment Column : Lidco | 27-Oct-2010 | The Independent |
Price | 9,694.19 |
Closing Price Change | 494.22 |
% Change | 5.37 % |
02-Jun-25 Close | 9,694.19 |
You are here: research